Filing Details

Accession Number:
0001493152-22-023502
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-18 19:35:09
Reporting Period:
2022-08-17
Accepted Time:
2022-08-18 19:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841330 Pasithea Therapeutics Corp. KTTA () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516478 Camac Fund, Lp Camac Capital, Llc
350 Park Avenue, 13Th Floor
New York NY 10022
No No No Yes
1790877 Eric Shahinian C/O Camac Partners, Llc
350 Park Avenue, 13Th Floor
New York NY 10022
No No No Yes
1867496 Camac Partners, Llc 350 Park Avenue
13Th Floor
New York NY 10022
No No No Yes
1867498 Camac Capital, Llc 350 Park Avenue
13Th Floor
New York NY 10022
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-17 155,773 $1.21 1,611,329 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.